Abstract
The anemia of erythroblastotic infants can be predicted antenatally by the indirect Coombs test, amniotic fluid pigment levels and maternal excretion of chorionic gonadotrophin. The only effective therapy for fetal anemia is delivery before the development of fetal hydrops. This may be accomplished by focusing attention on factors indicative of fetal anemia and by delivering potentially anemic fetuses as soon as they are sufficiently mature to escape the problems of prematurity.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BEVIS D. C. A. The composition of liquor amnii in haemolytic disease of the newborn. J Obstet Gynaecol Br Emp. 1953 Apr;60(2):244–251. doi: 10.1111/j.1471-0528.1953.tb07683.x. [DOI] [PubMed] [Google Scholar]
- BIERING G., KAISER I., KRIVIT W. Prognosis of fetuses at 33 weeks' gestation in Rh-sensitized women who have had preceding stillbirths. J Lancet. 1959 Jun;79(6):277–283. [PubMed] [Google Scholar]
- KELSALL G. A., VOS G. H., KIRK R. L. Case for induction of labour in treatment of haemolytic disease of the newborn. Br Med J. 1958 Aug 23;2(5094):468–473. doi: 10.1136/bmj.2.5094.468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RIGSBY W. C., VORYS N., COPELAND W. E., ULLERY J. C. Antenatal diagnosis of the Rh erythroblastotic fetus. Obstet Gynecol. 1961 Nov;18:579–590. [PubMed] [Google Scholar]